Literature DB >> 25015836

Assessment and outcome of children with intestinal failure referred for intestinal transplantation.

S Ganousse-Mazeron1, F Lacaille1, V Colomb-Jung1, C Talbotec1, F Ruemmele1, F Sauvat2, C Chardot2, D Canioni3, D Jan2, Y Revillon2, O Goulet4.   

Abstract

BACKGROUND & AIMS: Chronic intestinal failure (CIF) requires long term parenteral nutrition (PN) and, in some patients, intestinal transplantation (ITx). Indications and timing for ITx remain poorly defined. In the present study we aimed to analyze causes and outcome of children with CIF.
METHODS: 118 consecutive patients referred to our institution were assessed by a multidisciplinary team and four different categories were defined retrospectively based on their clinical course: Group 1: patients with reversible intestinal failure; group 2: patients unsuitable for ITx, group 3: patients listed for ITx; group 4: patients stable under PN. Analysis involved comparison between groups for nutritional status, central venous catheter (CVC) related complications, liver disease, and outcome after transplantation by using non parametric tests, Mann-Whitney tests, Kruskal-Wallis, Wilcoxon signed rank tests and chi square distribution for percentage.
RESULTS: 118 children (72 boys) with a median age of 15 months at referral (2 months-16 years) were assessed. Etiology of IF was short bowel syndrome [n = 47], intractable diarrhea of infancy [n = 37], total intestinal aganglionosis [n = 18], and chronic intestinal pseudoobstruction [n = 17]. Most patients (89.8%) were totally PN dependent, with 48 children (40.7%) on home-PN prior to admission. Nutritional status was poor with a median body weight at -1.5 z-score (ranges: -5 to +2.5) and median length at -2.0 z-score (ranges: -5.5 to +2.3). The mean number of CVC inserted per patient was 5.2 (range 1-20) and the mean number of CRS per patient was 5.5 (median: 5; range 0-12) Fifty-five patients (46.6%) had thrombosis of ≥2 main venous axis. At admission 34.7% of patients had elevated bilirubin (≥50 μmol/l), and 19.5% had platelets <100,000/ml, and 15% had both. Liver biopsy performed in 79 children was normal (n = 4), or showed F1 or F2 fibrosis (n = 29), bridging fibrosis F3 (n = 20), or cirrhosis (n = 26). Group 1 included 10 children finally weaned from PN (7-years survival: 100%). Group 2 included 12 children with severe liver disease and associated disorders unsuitable for transplantation (7-years survival: 16.6%). Group 3 included 66 patients (56%) who were listed for small bowel or liver-small bowel transplantation, 62/66 have been transplanted (7 years survival: 74.6%). Factors influencing outcome after liver-ITx were body weight (p < .004), length (p < .001), pre-Tx bilirubin plasma level (p < .001) and thrombosis (p < .01) for isolated ITx, Group 4 included 30 children (25.4%) with irreversible IF considered as potential candidates for isolated ITx. Four children were lost from follow up and 3 died within 2 years (survival 88.5%). Among potential candidates, the following parameters improved significantly during the first 12 months of follow up: Body weight (p.0001), length (p < .0001) and bilirubin (p < .0001).
CONCLUSIONS: many patients had a poor nutritional status with severe complications especially liver disease. PN related complications were the most relevant indication for ITx, but also a negative predictor for outcome. Early patient referral for Tx-assessment might help to identify and separate children with irreversible IF from children with transient IF or uncomplicated long-term PN, allowing to adapt a patient-based treatment strategy including or not ITx.
Copyright © 2014 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Cholestasis; Intestinal failure; Intestinal rehabilitation; Intestinal transplantation; Parenteral nutrition; Short bowel syndrome

Mesh:

Substances:

Year:  2014        PMID: 25015836     DOI: 10.1016/j.clnu.2014.04.015

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  16 in total

1.  No Gut No Gain! Enteral Bile Acid Treatment Preserves Gut Growth but Not Parenteral Nutrition-Associated Liver Injury in a Novel Extensive Short Bowel Animal Model.

Authors:  Gustavo Villalona; Amber Price; Keith Blomenkamp; Chandrashekhara Manithody; Saurabh Saxena; Thomas Ratchford; Matthew Westrich; Vindhya Kakarla; Shruthika Pochampally; William Phillips; Nicole Heafner; Niraja Korremla; Jose Greenspon; Miguel A Guzman; Ajay Kumar Jain
Journal:  JPEN J Parenter Enteral Nutr       Date:  2018-04-27       Impact factor: 4.016

Review 2.  Intestinal organoids in infants and children.

Authors:  Sinobol Chusilp; Bo Li; Dorothy Lee; Carol Lee; Paisarn Vejchapipat; Agostino Pierro
Journal:  Pediatr Surg Int       Date:  2019-09-25       Impact factor: 1.827

Review 3.  New Insights Into Intestinal Failure-Associated Liver Disease in Children.

Authors:  Racha T Khalaf; Ronald J Sokol
Journal:  Hepatology       Date:  2020-03-18       Impact factor: 17.425

Review 4.  Autologous intestinal reconstruction surgery as part of comprehensive management of intestinal failure.

Authors:  Mikko P Pakarinen
Journal:  Pediatr Surg Int       Date:  2015-03-29       Impact factor: 1.827

5.  Developing a Novel Ambulatory Total Parenteral Nutrition-Dependent Short Bowel Syndrome Animal Model.

Authors:  Amber Price; Keith Blomenkamp; Chandrashekhara Manithody; Saurabh Saxena; Salim Munoz Abraham; Jose Greenspon; Gustavo A Villalona; Ajay Kumar Jain
Journal:  J Surg Res       Date:  2018-09-27       Impact factor: 2.192

6.  Low-Dose Parenteral Soybean Oil for the Prevention of Parenteral Nutrition-Associated Liver Disease in Neonates With Gastrointestinal Disorders.

Authors:  Kara L Calkins; Thomas Havranek; Lorraine I Kelley-Quon; Laura Cerny; Martiniano Flores; Tristan Grogan; Stephen B Shew
Journal:  JPEN J Parenter Enteral Nutr       Date:  2016-07-11       Impact factor: 4.016

7.  A meta-analysis of clinical outcome of intestinal transplantation in patients with total intestinal aganglionosis.

Authors:  Hiroki Nakamura; Davina Henderson; Prem Puri
Journal:  Pediatr Surg Int       Date:  2017-06-09       Impact factor: 1.827

8.  Early detection of liver fibrosis with serum Mac-2 binding protein glycosylation-modified isomer (M2BPGi) during follow-up intestinal failure patients without intestinal failure-associated liver disease (IFALD).

Authors:  Takehisa Ueno; Koki Takase; Koichi Deguchi; Kazunori Masahata; Motonari Nomura; Miho Watanabe; Masafumi Kamiyama; Yuko Tazuke; Kazuhiko Bessho; Hiroomi Okuyama
Journal:  Pediatr Surg Int       Date:  2022-09-20       Impact factor: 2.003

9.  Development and validation of an ambulatory piglet model for short bowel syndrome with ileo-colonic anastomosis.

Authors:  Chandrashekhara Manithody; Christine Denton; Amber Price; Keith Blomenkamp; Yogi Patel; Adam Welu; Ester Glbert; Himani Madnawat; Sonali Jain; Gustavo A Villalona; Ajay K Jain
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-07

10.  NF-κB Regulation of LRH-1 and ABCG5/8 Potentiates Phytosterol Role in the Pathogenesis of Parenteral Nutrition-Associated Cholestasis.

Authors:  Swati Ghosh; Michael W Devereaux; Aimee L Anderson; Sarah Gehrke; Julie A Reisz; Angelo D'Alessandro; David J Orlicky; Mark Lovell; Karim C El Kasmi; Colin T Shearn; Ronald J Sokol
Journal:  Hepatology       Date:  2021-08-27       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.